David Hoel to Dose-Response Relationship, Drug
This is a "connection" page, showing publications David Hoel has written about Dose-Response Relationship, Drug.
Connection Strength
0.356
-
Nonlinearity of dose-response functions for carcinogenicity. Environ Health Perspect. 1994 Jan; 102 Suppl 1:109-13.
Score: 0.084
-
Biologically-based risk estimation for radiation-induced chronic myeloid leukemia. Radiat Environ Biophys. 2000 Sep; 39(3):153-9.
Score: 0.033
-
Incorporation of background in dose-response models. Fed Proc. 1980 Jan; 39(1):73-5.
Score: 0.032
-
Assumptions of the HERP Index. Risk Anal. 1990 Dec; 10(4):623-4; discussion 629-33.
Score: 0.017
-
Metabolite-based internal doses used in a risk assessment of benzene. Environ Health Perspect. 1989 Jul; 82:177-84.
Score: 0.015
-
The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988 Nov; 9(11):2045-52.
Score: 0.015
-
Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75.
Score: 0.014
-
Issues concerning the estimation of the TD50. Risk Anal. 1987 Dec; 7(4):437-47.
Score: 0.014
-
Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride. Risk Anal. 1986 Jun; 6(2):155-66.
Score: 0.012
-
An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data. Fundam Appl Toxicol. 1986 Feb; 6(2):263-9.
Score: 0.012
-
Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol. 1985 Feb; 5(1):79-86.
Score: 0.011
-
Design of animal carcinogenicity studies for goodness-of-fit of multistage models. Fundam Appl Toxicol. 1984 Dec; 4(6):949-59.
Score: 0.011
-
Modeling time-to-tumor data: analysis of the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):458-69.
Score: 0.010
-
Multistage prediction of cancer in serially dosed animals with application to the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):470-7.
Score: 0.010
-
Optimal design of the chronic animal bioassay. J Toxicol Environ Health. 1983 Jul; 12(1):1-19.
Score: 0.010
-
Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983 Mar 04; 219(4588):1032-7.
Score: 0.010
-
Statistical measures of risk. Drug Metab Rev. 1982; 13(5):829-38.
Score: 0.009
-
Animal experimentation and its relevance to man. Environ Health Perspect. 1979 Oct; 32:25-30.
Score: 0.008
-
The effect of dose on cancer latency period. J Environ Pathol Toxicol. 1977 Nov-Dec; 1(2):279-86.
Score: 0.007
-
Occupational carcinogenesis. Statistical extrapolation methods for estimating risks from animal data. Ann N Y Acad Sci. 1976; 271:418-20.
Score: 0.006
-
Estimation of risks of irreversible, delayed toxicity. J Toxicol Environ Health. 1975 Sep; 1(1):133-51.
Score: 0.006
-
Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res. 1991 Dec 01; 51(23 Pt 2):6409-14.
Score: 0.005
-
Some practical problems arising from use of the gamma multihit model for risk estimation. J Toxicol Environ Health. 1981 Sep; 8(3):379-86.
Score: 0.002
-
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. Toxicol Appl Pharmacol. 1980 Aug; 55(1):154-61.
Score: 0.002
-
Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 1976 Sep; 36(9 pt.1):2973-9.
Score: 0.002